{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:49:49Z","timestamp":1775069389351,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.neuro.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T21:15:31Z","timestamp":1602537331000},"page":"147-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments"],"prefix":"10.1016","volume":"81","author":[{"given":"Vivek","family":"Lawana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0291-3669","authenticated-orcid":false,"given":"Se Young","family":"Um","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5593-938X","authenticated-orcid":false,"given":"Rachel M.","family":"Foguth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-4555","authenticated-orcid":false,"given":"Jason R.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2020.10.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/672838","article-title":"Dietary factors in the etiology of Parkinson\u2019s disease","author":"Agim","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.neuro.2020.10.005_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxlet.2018.01.017","article-title":"Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure","volume":"287","author":"Agim","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.neuro.2020.10.005_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/1353-8020(96)00004-1","article-title":"Lack of toxicity of human neuromelanin to rat brain dopaminergic neurons","volume":"2","author":"Aimi","year":"1996","journal-title":"Parkinsonism Relat. Disord."},{"issue":"23","key":"10.1016\/j.neuro.2020.10.005_bib0020","doi-asserted-by":"crossref","first-page":"9368","DOI":"10.1073\/pnas.87.23.9368","article-title":"Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine","volume":"87","author":"Albores","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/1531-8257(199901)14:1<21::AID-MDS1006>3.0.CO;2-Y","article-title":"Dietary factors in Parkinson\u2019s disease: the role of food groups and specific foods","volume":"14","author":"Anderson","year":"1999","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.neuro.2020.10.005_bib0030","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.neuro.2020.10.005_bib0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.nrleng.2012.04.022","article-title":"Parkinson\u2019s disease and Alzheimer disease: environmental risk factors","volume":"29","author":"Campdelacreu","year":"2014","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"9","key":"10.1016\/j.neuro.2020.10.005_bib0040","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1021\/ic060014r","article-title":"Fe(III)-coordination properties of neuromelanin components: 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid","volume":"45","author":"Charkoudian","year":"2006","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.neuro.2020.10.005_bib0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuro.2018.01.009","article-title":"Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons","volume":"65","author":"Cruz-Hernandez","year":"2018","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.1016\/j.neuro.2020.10.005_bib0050","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4161\/auto.6458","article-title":"Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson\u2019s disease","volume":"4","author":"Dagda","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.neuro.2020.10.005_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson\u2019s disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.neuro.2020.10.005_bib0060","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jep.2017.02.021","article-title":"Lumbee traditional medicine: neuroprotective activities of medicinal plants used to treat Parkinson\u2019s disease-related symptoms","volume":"206","author":"de Rus Jacquet","year":"2017","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.neuro.2020.10.005_bib0065","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.freeradbiomed.2010.08.028","article-title":"Neuroprotection by a mitochondria-targeted drug in a Parkinson\u2019s disease model","volume":"49","author":"Ghosh","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.neuro.2020.10.005_bib0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(92)90719-P","article-title":"Melanin, Tyrosine-Hydroxylase, Calbindin and Substance-P in the human midbrain and Substantia-Nigra in relation to nigrostriatal projections and differential neuronal susceptibility in parkinsons-disease","volume":"581","author":"Gibb","year":"1992","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/toxsci\/kfu060","article-title":"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitro","volume":"140","author":"Griggs","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.neuro.2020.10.005_bib0080","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/ijms11031082","article-title":"Tyrosinase-expressing neuronal cell line as in vitro model of Parkinson\u2019s disease","volume":"11","author":"Hasegawa","year":"2010","journal-title":"Int. J. Mol. Sci."},{"issue":"6180","key":"10.1016\/j.neuro.2020.10.005_bib0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic-neurons are differentially susceptible to degeneration in Parkinsons-disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.neuro.2020.10.005_bib0090","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1016\/0006-2952(88)90641-7","article-title":"Effects of heterocyclic amines in food on dopamine metabolism in nigro-striatal dopaminergic-neurons","volume":"37","author":"Ichinose","year":"1988","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.neuro.2020.10.005_bib0095","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1016\/S1353-8020(11)70057-8","article-title":"Animal models of Parkinson\u2019s disease","volume":"18","author":"Jackson-Lewis","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuro.2020.10.005_bib0100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0072-9752(07)83024-7","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"83","author":"Jenner","year":"2007","journal-title":"Handb. Clin. Neurol."},{"issue":"6","key":"10.1016\/j.neuro.2020.10.005_bib0105","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/ije\/28.6.1102","article-title":"Adult nutrient intake as a risk factor for Parkinson\u2019s disease","volume":"28","author":"Johnson","year":"1999","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.neuro.2020.10.005_bib0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-6606-1-12","article-title":"Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): implications for neurodegeneration in Parkinson\u2019s disease","volume":"1","author":"Kanthasamy","year":"2008","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1755-148X.2008.00508.x","article-title":"Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells - a possible link between Parkinson-dementia complex and pigmentary retinopathy","volume":"22","author":"Karlsson","year":"2009","journal-title":"Pigment Cell Melanoma Res."},{"issue":"2","key":"10.1016\/j.neuro.2020.10.005_bib0120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.expneurol.2009.09.025","article-title":"Cybrid models of Parkinson\u2019s disease show variable mitochondrial biogenesis and genotype-respiration relationships","volume":"220","author":"Keeney","year":"2009","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0197-0186(90)90122-A","article-title":"3-amino-1-Methyl-5h-Pyrido[4,3-B]Indole (Trp-P-2) and other heterocyclic amines as inhibitors of mitochondrial monoamine oxidases separated from human brain synaptosomes","volume":"16","author":"Kojima","year":"1990","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.neuro.2020.10.005_bib0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.25292","article-title":"The current and projected economic burden of Parkinson\u2019s disease in the United States","volume":"28","author":"Kowal","year":"2013","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.neuro.2020.10.005_bib0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1600-0404.1995.tb00479.x","article-title":"Plasma levels of the beta-carbolines harman and norharman in Parkinson\u2019s disease","volume":"92","author":"Kuhn","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuro.2020.10.005_bib0140","first-page":"291","article-title":"Plasma harman and norharman in Parkinson\u2019s disease","volume":"46","author":"Kuhn","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"issue":"12","key":"10.1016\/j.neuro.2020.10.005_bib0145","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/BF01271257","article-title":"Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients","volume":"103","author":"Kuhn","year":"1996","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"4","key":"10.1016\/j.neuro.2020.10.005_bib0150","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.neuro.2020.10.005_bib0155","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s11481-017-9746-5","article-title":"Involvement of c-Abl kinase in microglial activation of NLRP3 inflammasome and impairment in autolysosomal system","volume":"12","author":"Lawana","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/toxsci\/kfz210","article-title":"Neuromelanin modulates heterocyclic aromatic amine-induced dopaminergic neurotoxicity","volume":"173","author":"Lawana","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson\u2019s disease linked to pathological alpha-synuclein: new targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(88)90002-X","article-title":"Autoradiography of [C-14] paraquat or [C-14] diquat in frogs and mice - accumulation in neuromelanin","volume":"93","author":"Lindquist","year":"1988","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.410390113","article-title":"Dietary lipids and antioxidants in Parkinson\u2019s disease: a population-based, case-control study","volume":"39","author":"Logroscino","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuro.2020.10.005_bib0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuro.2013.11.005","article-title":"Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in Parkinson\u2019s disease","volume":"40","author":"Louis","year":"2014","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.neuro.2020.10.005_bib0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0047-6374(83)90074-X","article-title":"Possible role of Neuromelanin in the pathogenesis of Parkinsons-disease","volume":"21","author":"Mann","year":"1983","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuro.2020.10.005_bib0190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-4757-3538-3_64","article-title":"Biosynthesis of neuromelanin and melanin: the potential involvement of macrophage inhibitory factor and dopachrome tautomerase as rescue enzymes","volume":"53","author":"Matsunaga","year":"2002","journal-title":"Adv. Behav. Biol."},{"issue":"6","key":"10.1016\/j.neuro.2020.10.005_bib0195","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0306-3623(84)90212-X","article-title":"Tyrosinase-like activity in normal human substantia nigra","volume":"15","author":"Miranda","year":"1984","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.neuro.2020.10.005_bib0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson\u2019s disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.neuro.2020.10.005_bib0205","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/oxfordjournals.jbchem.a134053","article-title":"Acridine orange as a fluorescent probe for lysosomal proton pump","volume":"92","author":"Moriyama","year":"1982","journal-title":"J. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2020.10.005_bib0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0006-8993(95)00082-2","article-title":"Methyl-beta-carbolinium analogs of MPP+ cause nigrostriatal toxicity after substantia nigra injections in rats","volume":"675","author":"Neafsey","year":"1995","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neuro.2020.10.005_bib0215","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00702-006-0622-3","article-title":"Differential effects of dopamine melanin on norharman-induced toxicity in PC12 cells","volume":"114","author":"Ostergren","year":"2007","journal-title":"J. Neural Transm."},{"issue":"27","key":"10.1016\/j.neuro.2020.10.005_bib0220","doi-asserted-by":"crossref","first-page":"10058","DOI":"10.1523\/JNEUROSCI.0302-15.2015","article-title":"Fyn kinase regulates microglial neuroinflammatory responses in cell culture and animal models of Parkinson\u2019s disease","volume":"35","author":"Panicker","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2020.10.005_bib0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jchemneu.2015.02.001","article-title":"Using Sepia melanin as a PD model to describe the binding characteristics of neuromelanin - A critical review","volume":"64-65","author":"Schroeder","year":"2015","journal-title":"J. Chem. Neuroanat."},{"issue":"10\u201311","key":"10.1016\/j.neuro.2020.10.005_bib0230","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00702-004-0211-2","article-title":"Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells","volume":"111","author":"Shamoto-Nagai","year":"2004","journal-title":"J. Neural Transm."},{"issue":"5","key":"10.1016\/j.neuro.2020.10.005_bib0235","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00702-005-0410-5","article-title":"Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome","volume":"113","author":"Shamoto-Nagai","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuro.2020.10.005_bib0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nbd.2018.05.019","article-title":"Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: implications for mitochondria mediated oxidative stress signaling events","volume":"117","author":"Singh","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"9\u201310","key":"10.1016\/j.neuro.2020.10.005_bib0245","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0278-6915(98)00061-1","article-title":"Carcinogenic heterocyclic amines in model systems and cooked foods: a review on formation, occurrence and intake","volume":"36","author":"Skog","year":"1998","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.neuro.2020.10.005_bib0250","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2006.10.018","article-title":"Formation and biochemistry of carcinogenic heterocyclic aromatic amines in cooked meats","volume":"168","author":"Turesky","year":"2007","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.neuro.2020.10.005_bib0255","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.1994.62031097.x","article-title":"Iron and other metals in Neuromelanin, substantia-nigra, and putamen of human brain","volume":"62","author":"Zecca","year":"1994","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1010650729843","article-title":"The determination of iron and other metals by INAA in Cortex, Cerebellum and Putamen of human brain and in their neuromelanins","volume":"248","author":"Zecca","year":"2001","journal-title":"J. Radioanal. Nucl. Chem."},{"issue":"3","key":"10.1016\/j.neuro.2020.10.005_bib0265","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","article-title":"The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson\u2019s disease","volume":"510","author":"Zecca","year":"2002","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.neuro.2020.10.005_bib0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-009-9140-z","article-title":"Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuro.2020.10.005_bib0275","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog. Neurobiol."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X20301777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X20301777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:23:13Z","timestamp":1758982993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X20301777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":55,"alternative-id":["S0161813X20301777"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2020.10.005","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}